Literature DB >> 34985665

More than a Gender Issue: Testis as a Distinctive HIV Reservoir and Its Implication for Viral Eradication.

Jean-Pierre Routy1,2,3, Franck P Dupuy4,5, John Lin4,5, Stéphane Isnard4,5,6.   

Abstract

Early establishment of HIV reservoir represents the main impediment to an HIV cure. Mainly composed of infected memory CD4 T-cells and macrophages, HIV reservoirs are found in several organs including lymph nodes, gut, and testes. In men, and as seen in brain and eyes, testes represent a distinctive organ characterized by an immune privilege, allowing the tolerance of spermatozoa which only develop after puberty, long after the establishment of systemic immunity. The immune privilege of testes relies on a strict testis-blood barrier, and a local immunosuppressive environment. Testes has been described as reservoir for several viruses including Ebola, Zika, and HIV. Indeed, HIV reservoirs were detected in tested viremic and virally suppressed donor taking antiretroviral therapy (ART). Herein, we discuss the distinctive environment found in human testes and describe a validated method allowing the characterization and quantification of HIV-infected CD4 T-cells in human testes. Using mechanical and enzymatic treatment, cells can be extracted from human testis samples. Characterization of those cells can be performed by flow cytometry and HIV reservoir quantification performed by nested qPCR after flow cytometry sorting.
© 2022. Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  CD4 T-cell; Flow cytometry; HIV; PCR; Reservoir; Testis; Tissue

Mesh:

Year:  2022        PMID: 34985665     DOI: 10.1007/978-1-0716-1871-4_13

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  59 in total

1.  Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy.

Authors:  D Finzi; J Blankson; J D Siliciano; J B Margolick; K Chadwick; T Pierson; K Smith; J Lisziewicz; F Lori; C Flexner; T C Quinn; R E Chaisson; E Rosenberg; B Walker; S Gange; J Gallant; R F Siliciano
Journal:  Nat Med       Date:  1999-05       Impact factor: 53.440

2.  Precise Quantitation of the Latent HIV-1 Reservoir: Implications for Eradication Strategies.

Authors:  Amanda M Crooks; Rosalie Bateson; Anna B Cope; Noelle P Dahl; Morgan K Griggs; JoAnn D Kuruc; Cynthia L Gay; Joseph J Eron; David M Margolis; Ronald J Bosch; Nancie M Archin
Journal:  J Infect Dis       Date:  2015-04-15       Impact factor: 5.226

3.  Clonal expansion of genome-intact HIV-1 in functionally polarized Th1 CD4+ T cells.

Authors:  Guinevere Q Lee; Nina Orlova-Fink; Kevin Einkauf; Fatema Z Chowdhury; Xiaoming Sun; Sean Harrington; Hsiao-Hsuan Kuo; Stephane Hua; Hsiao-Rong Chen; Zhengyu Ouyang; Kavidha Reddy; Krista Dong; Thumbi Ndung'u; Bruce D Walker; Eric S Rosenberg; Xu G Yu; Mathias Lichterfeld
Journal:  J Clin Invest       Date:  2017-06-19       Impact factor: 14.808

4.  PLA2G1B is involved in CD4 anergy and CD4 lymphopenia in HIV-infected patients.

Authors:  Julien Pothlichet; Thierry Rose; Florence Bugault; Louise Jeammet; Annalisa Meola; Ahmed Haouz; Frederick Saul; David Geny; José Alcami; Ezequiel Ruiz-Mateos; Luc Teyton; Gérard Lambeau; Jacques Thèze
Journal:  J Clin Invest       Date:  2020-06-01       Impact factor: 14.808

5.  CD4+ T Cells Expressing PD-1, TIGIT and LAG-3 Contribute to HIV Persistence during ART.

Authors:  Rémi Fromentin; Wendy Bakeman; Mariam B Lawani; Gabriela Khoury; Wendy Hartogensis; Sandrina DaFonseca; Marisela Killian; Lorrie Epling; Rebecca Hoh; Elizabeth Sinclair; Frederick M Hecht; Peter Bacchetti; Steven G Deeks; Sharon R Lewin; Rafick-Pierre Sékaly; Nicolas Chomont
Journal:  PLoS Pathog       Date:  2016-07-14       Impact factor: 6.823

6.  New insights into the heterogeneity of Th17 subsets contributing to HIV-1 persistence during antiretroviral therapy.

Authors:  Vanessa Sue Wacleche; Jean-Philippe Goulet; Annie Gosselin; Patricia Monteiro; Hugo Soudeyns; Rémi Fromentin; Mohammad-Ali Jenabian; Shant Vartanian; Steven G Deeks; Nicolas Chomont; Jean-Pierre Routy; Petronela Ancuta
Journal:  Retrovirology       Date:  2016-08-24       Impact factor: 4.602

7.  HIV persists in CCR6+CD4+ T cells from colon and blood during antiretroviral therapy.

Authors:  Annie Gosselin; Tomas Raul Wiche Salinas; Delphine Planas; Vanessa S Wacleche; Yuwei Zhang; Rémi Fromentin; Nicolas Chomont; Éric A Cohen; Barbara Shacklett; Vikram Mehraj; Maged P Ghali; Jean-Pierre Routy; Petronela Ancuta
Journal:  AIDS       Date:  2017-01-02       Impact factor: 4.177

8.  Blood CXCR3+ CD4 T Cells Are Enriched in Inducible Replication Competent HIV in Aviremic Antiretroviral Therapy-Treated Individuals.

Authors:  Riddhima Banga; Francesco A Procopio; Alessandra Ruggiero; Alessandra Noto; Khalid Ohmiti; Matthias Cavassini; Jean-Marc Corpataux; William A Paxton; Georgios Pollakis; Matthieu Perreau
Journal:  Front Immunol       Date:  2018-02-05       Impact factor: 7.561

9.  Single-cell characterization and quantification of translation-competent viral reservoirs in treated and untreated HIV infection.

Authors:  Marion Pardons; Amy E Baxter; Marta Massanella; Amélie Pagliuzza; Rémi Fromentin; Caroline Dufour; Louise Leyre; Jean-Pierre Routy; Daniel E Kaufmann; Nicolas Chomont
Journal:  PLoS Pathog       Date:  2019-02-27       Impact factor: 6.823

10.  Altered differentiation is central to HIV-specific CD4+ T cell dysfunction in progressive disease.

Authors:  Antigoni Morou; Elsa Brunet-Ratnasingham; Mathieu Dubé; Roxanne Charlebois; Eloi Mercier; Sam Darko; Nathalie Brassard; Krystelle Nganou-Makamdop; Sahaana Arumugam; Gabrielle Gendron-Lepage; Lifei Yang; Julia Niessl; Amy E Baxter; James M Billingsley; Premeela A Rajakumar; François Lefebvre; R Paul Johnson; Cécile Tremblay; Jean-Pierre Routy; Richard T Wyatt; Andrés Finzi; Daniel C Douek; Daniel E Kaufmann
Journal:  Nat Immunol       Date:  2019-07-15       Impact factor: 25.606

View more
  1 in total

1.  Monkeypox 2022 Identify-Isolate-Inform: A 3I Tool for frontline clinicians for a zoonosis with escalating human community transmission.

Authors:  Kristi L Koenig; Christian K Beÿ; Aileen M Marty
Journal:  One Health       Date:  2022-06-24
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.